Congenital Heart Surgery in Pediatric Patients With Beta-Thalassemia Major

Congenital Heart Surgery in Pediatric Patients With Beta-Thalassemia Major : Analysis of Hemolysis During Cardiopulmonary Bypass

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04367701

Enrollment

Registered

2020-04-29

Start date

2012-01-15

Completion date

2019-08-30

Last updated

2020-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemolysis

Brief summary

Authors compared incidence of Hemolysis on Cardiopulmonary Bypass surgery for repair of congenital heart disease in Pediatric Patients between patients with thalassemia major and control group

Interventions

DIAGNOSTIC_TESTHemolysis

Authors measured free plasma hemoglobin concentration in gram

Study design

Observational model

CASE_CROSSOVER

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

6 Months to 12 Years

Inclusion criteria

* Pediatric Patients with thalassemia major. * Pediatric Patients with congenital heart disease undergoing surgical repair.

Exclusion criteria

* known hepatic or renal disease * uncontrolled active hemolytic reaction * emergency surgery * redo surgery

Design outcomes

Primary

Measure	Time frame	Description
Hemolysis	3 hours	Authors measure hemolysis by free plasma hemoglobin concentration

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026